GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
ODAC Votes Against Oncopeptides’ and Spectrum’s New Oncology Drugs
2022-09-26
AstraZeneca’s Rare Disease Treatment Wins Third Approval in European Union
2022-09-23
AstraZeneca Blocks Ionis’ Hypercholesterolemia Treatment from Moving into a Phase 3 Study
2022-09-23
Novo Nordisk’s Once-Weekly Insulin Snags Another Victory
2022-09-22
Fennec’s PEDMARK Finally Gains FDA Approval to Treat Chemo-Induced Hearing Loss
2022-09-22
BridgeBio and Sentynl Therapeutics’ Nulibry Gets Greenlighted In Europe
2022-09-21
AVROBIO’s First-of-its-Kind Gene Therapy Receives Rare Pediatric Disease Designation
2022-09-21
AstraZeneca’s Treatment for COVID-19 Wins European Approval
2022-09-20
Merck’s Phase 2 HIV Treatment Study Resumes with Phase 3 Program Announcement
2022-09-20
Aurinia Wins Approval For Lupus Nephritis Therapy In Europe
2022-09-20
1 2 3 39
LATEST
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!